Other
Other
Moderna Other increased by 268.8% to $59M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 96.7%, from $30M to $59M. Over 5 years (FY 2020 to FY 2025), Other shows an upward trend with a 32.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Metric ID:
other_other_sundry_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66M | $12M | $14M | $34M | $250M | $293M | $53M | $31M | $15M | $56M | $41M | $46M | $17M | $18M | $23M | $30M | $31M | $25M | $16M | $59M |
| QoQ Change | — | -81.8% | +16.7% | +142.9% | +635.3% | +17.2% | -81.9% | -41.5% | -51.6% | +273.3% | -26.8% | +12.2% | -63.0% | +5.9% | +27.8% | +30.4% | +3.3% | -19.4% | -36.0% | +268.8% |
| YoY Change | — | — | — | — | +278.8% | >999% | +278.6% | -8.8% | -94.0% | -80.9% | -22.6% | +48.4% | +13.3% | -67.9% | -43.9% | -34.8% | +82.4% | +38.9% | -30.4% | +96.7% |
Range$12M – $293M
CAGR-2.3%
Avg YoY Growth+174.7%
Median YoY Growth+2.3%
Other at Other Companies
Frequently Asked Questions
- What is Moderna's other?
- Moderna (MRNA) reported other of $59M in Q1 2026.
- How has Moderna's other changed year-over-year?
- Moderna's other increased by 96.7% year-over-year, from $30M to $59M.
- What is the long-term trend for Moderna's other?
- Over 5 years (2020 to 2025), Moderna's other has grown at a 32.0% compound annual growth rate (CAGR), from $4M to $16M.